FENNEC PHARMACEUTICALS INC. Stock Issued During Period, Shares, New Issues
FENNEC PHARMACEUTICALS INC. (FENC) had Stock Issued During Period, Shares, New Issues of 4.80 million shares as of 2020-05-07, per its 10-Q filed 2020-11-16.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2022-02-28
- 2020-05-07: Stock Issued During Period, Shares, New Issues 4.80M shares.
- 2020-05-05: Stock Issued During Period, Shares, New Issues 4.80M shares.
| Period end | Stock Issued During Period, Shares, New Issues |
|---|---|
| 2020-05-07 | 4.80M shares 10-Q · filed 2020-11-16 |
| 2020-05-05 | 4.80M shares 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |